Trump Diagnosed with Common Vein Condition

White House: No Serious Health Concerns

Translate to Spanish or other 102 languages!

President Donald Trump has been diagnosed with chronic venous insufficiency, a common vascular condition that affects blood flow in the legs. Image for illustration purposes
President Donald Trump has been diagnosed with chronic venous insufficiency, a common vascular condition that affects blood flow in the legs. Image for illustration purposes
- Advertisement -

Mega Doctor News

President Donald Trump has been diagnosed with chronic venous insufficiency, a common vascular condition that affects blood flow in the legs. The announcement came Thursday, July 17, 2025, during a briefing by White House Press Secretary Karoline Leavitt.

“President Trump recently noticed mild swelling in his lower legs and sought medical evaluation out of an abundance of caution,” Leavitt stated. She explained that the former president underwent a series of vascular assessments, including Doppler ultrasounds, to determine the cause of the swelling.

- Advertisement -

The tests confirmed that Trump is experiencing chronic venous insufficiency, a condition in which the valves in the veins of the legs are unable to return blood efficiently to the heart, leading to fluid buildup and swelling. “This is a benign and manageable condition, frequently seen in older adults, particularly those over 70,” Leavitt said. “It is not life-threatening and does not impact his ability to travel, speak, or lead.”

According to the White House medical team, Trump’s diagnosis followed the exclusion of more serious conditions. “The president has tested negative for deep vein thrombosis, arterial disease, heart failure, and kidney dysfunction,” Leavitt reported. “His cardiovascular and renal health remain excellent.”

Chronic venous insufficiency affects approximately 5 percent of adults and is characterized by symptoms such as leg swelling, discoloration, and in some cases, skin ulcers. It is typically managed with compression garments, leg elevation, and lifestyle adjustments.

“President Trump is not experiencing discomfort and remains in excellent overall health,” Leavitt assured reporters. “His energy and daily activity level are unchanged, and he continues to fulfill his schedule without restriction.”

- Advertisement -

The announcement followed recent public speculation after photographs circulated online showing swelling in Trump’s lower legs during a campaign appearance. When asked about these concerns, Leavitt responded, “Out of transparency and care for public interest, we wanted to provide full clarity regarding the former president’s health.”

At this time, no additional medical interventions are planned beyond routine monitoring. “The president will continue to be evaluated regularly, as is standard for someone of his age and stature,” Leavitt added.

The White House emphasized that the condition poses no current health risk and does not interfere with Trump’s ongoing political activities.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Recognizes November as “National Hospice and Palliative Care” Month

DHR Health is pleased to recognize November as “National Hospice and Palliative Care Month.”  As we highlight National Hospice and Palliative Care Month, let us remember that healthcare is not solely about treating diseases but also about care for people at end of life.

STHS Heart Earns Healthgrades Five-Star Rating for Pacemaker Procedures

Healthgrades, the leading online resource for information about physicians and hospitals, has named STHS Heart a Five-Star Recipient for Pacemaker Procedures in 2027 for the second consecutive year, recognizing the facility's superior clinical outcomes and commitment to patient care.

AMA Advises Patients to Check with Doctors on Web Advice

The internet offers no shortage of health advice. But with misleading medical claims spread across social media, search engines, and AI platforms, finding trustworthy answers can be a challenge. 

FDA Authorizes Focused Ultrasound Treatment for Varicose Veins

Theraclion has announced that the US Food and Drug Administration (FDA) has granted De Novo authorization for its Sonovein device to treat superficial venous reflux in great saphenous veins (GSV), the main cause of varicose veins. This is the first noninvasive focused ultrasound platform to treat varicose veins, which affect approximately one third of adults.
- Advertisement -